TICAROS Co., Ltd
PrivateLast Round
Series D
Mar 3, 2026
Est. Valuation
$197.42M
Total Funding Raised
$42.5M
Company Overview
TICAROS Co., Ltd operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series D round in March 2026.
TICAROS Co., Ltd is a biotechnology company that develops next-generation CAR-T and CAR-NK cell therapies for cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TICAROS Co., Ltd Comparables
Compare TICAROS Co., Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InnoBation Bio | 83% | |
| Curocell | 81% | |
| AbClon Inc. | 78% |
For institutional investors. Book with your work email.
TICAROS Co., Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 3, 2026 | ||||
| Series C | Aug 24, 2021 | ||||
| Series B | Jan 9, 2020 | ||||
| Series A | Feb 1, 2019 |
For institutional investors. Book with your work email.
TICAROS Co., Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KIWOOM Securities Co., Ltd. | Series D |
| Shinhan Venture Investment | Series C |
| iM Investment Partners | Series D |
| Kingo Investment Partners | Series C |
| UTC Investment | Series C |
| Medici Investment | Series C |
| Daesung Private Equity | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2020
$5.24M round led by Medytox Venture Investment.
For institutional investors. Book with your work email.
TICAROS Co., Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TICAROS Co., Ltd's valuation, stock price, and market status.
Is TICAROS Co., Ltd a public or private company?
TICAROS Co., Ltd is a private company.
What is the current stock price of TICAROS Co., Ltd?
TICAROS Co., Ltd is a private company, so its shares have no public market price. Caplight tracks TICAROS Co., Ltd's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TICAROS Co., Ltd worth (valuation)?
TICAROS Co., Ltd's valuation is estimated at $197.4M based on funding round data.
Can I buy TICAROS Co., Ltd stock?
TICAROS Co., Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TICAROS Co., Ltd's last funding round?
TICAROS Co., Ltd's most recent funding round was Series D on March 3, 2026.
Who are the main investors in TICAROS Co., Ltd?
Key investors in TICAROS Co., Ltd include Medytox Venture Investment.
Will TICAROS Co., Ltd IPO soon?
No public IPO plans have been announced for TICAROS Co., Ltd.
How can I track TICAROS Co., Ltd secondary market activity?
Caplight tracks bids, offers, and trades in TICAROS Co., Ltd's shares on secondary markets.